EPA approval adds hospital-grade disinfection claims against 20+ pathogens including C. diff and MRSA, plus canine parvovirus and kennel cough, at a single 10-minute contact time. The animal-care angle differentiates the hypochlorous acid product in a market dominated by bleach and quats.
DT Pharmaceuticals (OTC: NDTP) said its Good Salt Life subsidiary won EPA approval for an expanded label on its Clean Republic Multipurpose Disinfectant. The new registration adds hospital-disinfectant claims covering more than 20 pathogens, including MRSA, tuberculosis, Norovirus, and C. diff spores, the company said in a release.
The product is an electrochemically activated hypochlorous acid solution at 500 ppm free available chlorine. The company positions it as a single-step cleaner that hits hospital-grade efficacy with a Category IV toxicity rating, the lowest acute toxicity classification. All the new kill claims are validated at a single 10-minute contact time on hard, non-porous surfaces, the release said.
The label expansion opens two distinct markets. On the healthcare side, the product now carries claims against C. diff spores, a persistent problem in hospital-acquired infections, and tuberculosis. On the animal care side, the label adds EPA-approved claims against canine parvovirus, canine distemper virus, and Bordetella bronchiseptica, the bacterium behind kennel cough.
“You shouldn’t have to choose between hospital disinfection performance and a thoughtfully formulated product for everyday use,” said Zach O’Shea, Chief Executive Officer of Good Salt Life, in the release.
The animal-care angle is the differentiator. Parvovirus is notoriously difficult to kill with standard quaternary ammonium disinfectants, and many shelters rely on bleach-based protocols that corrode surfaces and pose respiratory risks to staff and animals. An EPA-registered hypochlorous acid product with a parvovirus claim at a fixed 10-minute dwell time is relatively rare in the shelter market. The label also covers canine distemper and kennel cough, three of the most common infectious-disease threats in group housing for dogs.
The approved use sites in the label include hospitals, veterinary clinics, animal hospitals, day care centers, food preparation areas, schools, and industrial facilities. Because the product is already approved for food-contact surfaces, a single bottle can cover disinfection across a facility's kitchen, exam rooms, and kennels without switching chemistries.
Clean Republic Multipurpose Disinfectant is available through the company’s own store and major online retail channels. DT Pharmaceuticals is a holding company whose subsidiaries include Good Salt Life and a marine dock business.
The expanded label is a regulatory milestone for a small public company that manufactures its own chemistry in-house. The electrochemical process uses salt, water, and electricity to generate hypochlorous acid, avoiding the transportation and storage risks of concentrated bleach or peroxide chemistries. The question for the stock is whether the label can translate into institutional procurement cycles, which tend to move slowly. Shelters and hospitals do not switch disinfectants overnight, and the sales cycle for a new EPA-registered product in a regulated environment can run 12 to 18 months. O’Shea’s team will need to build distribution into veterinary supply chains and group-purchasing organizations for healthcare.
A photo accompanying the announcement is available at the company’s release page.
Prepared with AlphaScala editorial tooling from the source reporting linked above. Indexable analysis may include a cited Alpha Score value. Publishing checks screen each story before release. Educational coverage, not personalized advice.